guidepoint_MRK's profile picture. #KnowledgeSearch #ExpertNetworkService #ENS #Guidepoint

http://guidepoint.com

Mirae Kim

@guidepoint_MRK

#KnowledgeSearch #ExpertNetworkService #ENS #Guidepoint http://guidepoint.com

Pinned

Guidepoint (guidepoint.com) is a subject-matter expert matching platform that finds and connects industry experts suitable for client requests. It provides services to clients in various fields.


Mirae Kim reposted

Guidepoint is a primary market research network that delivers critical insight to business and investment professionals and non-profits via on-demand interactions with our global network of over 1,000,000 industry and subject matter experts. guidepoint.com.


Mirae Kim reposted

Guidepoint is hosting a virtual career mixer event for anyone interested in hearing from a panel of industry experts. Sign up asap! You won't want to miss this! tinyurl.com/GuidepointMixer

MagnerCenter's tweet image. Guidepoint is hosting a virtual career mixer event for anyone interested in hearing from a panel of industry experts.

Sign up asap! You won't want to miss this!
tinyurl.com/GuidepointMixer

Mirae Kim reposted

Did the collapse of #FTX derail crypto as an asset class? An antitrust professor and #cryptocurrency expert debates the need for a regulatory framework for #blockchain and #DeFi: bit.ly/3Vy7eLL

Guidepoint's tweet image. Did the collapse of #FTX derail crypto as an asset class? An antitrust professor and #cryptocurrency expert debates the need for a regulatory framework for #blockchain and #DeFi: bit.ly/3Vy7eLL

Mirae Kim reposted

On 11/2, $TNDM reported a weaker-than-anticipated 3Q22, with US sales coming below consensus. Despite sell-side estimates indicating that US sales would grow 3.7% Q/Q, Qsight Alpha DME data suggested Tandem sales were trending below consensus: bit.ly/34B2Ozb

Guidepoint's tweet image. On 11/2, $TNDM reported a weaker-than-anticipated 3Q22, with US sales coming below consensus. Despite sell-side estimates indicating that US sales would grow 3.7% Q/Q, Qsight Alpha DME data suggested Tandem sales were trending below consensus: bit.ly/34B2Ozb

Mirae Kim reposted

Doing work on $ABMD? We polled 25 interventional cardiologists on their Impella case volumes, growth expectations, and changes to indication mix. Check it out here: bit.ly/3h5MIDs

ICYMI: Johnson & Johnson will buy medical device company Abiomed in a $16.6 billion deal. cnb.cx/3fsjLkr



Mirae Kim reposted

Will Europe meet its 80% storage capacity target before winter? According to our Advisor, Germany appears to be in good shape for the upcoming winter season as long as weather conditions remain stable. #LNG #NatGas bit.ly/3Ad9GQf

GP_Insights's tweet image. Will Europe meet its 80% storage capacity target before winter? According to our Advisor, Germany appears to be in good shape for the upcoming winter season as long as weather conditions remain stable. #LNG #NatGas bit.ly/3Ad9GQf

Mirae Kim reposted

What is the growth outlook for Domtar with the US underperforming? How can the company take advantage of product innovation within packaging? The former VP of Corp Development and Strategy answers these questions. #CreditResearch bit.ly/3bNTXO1


Mirae Kim reposted

Guidepoint Insights hosted an expert discussion on Signify Health as press reports on the CVS potential bid. Learn more about the company's business model and value proposition from a former $SGFY executive. $CVS #homehealth bit.ly/3BTIjf5


Guidepoint: The Experts at Finding Expertise youtu.be/hrWUeNOs7Xw via @YouTube


How Can Guidepoint Help Corporate Clients? youtu.be/Hl2mYQNSzzg via @YouTube


Mirae Kim reposted

Press reports $PFE is in talks to buy $GBT. Guidepoint Insights recently hosted a call exploring GBT's development pipeline addressing SCD. Keep an eye out for KOL calls from us on this topic next week. bit.ly/3P4n1hE

Pfizer is in advanced talks to buy Global Blood Therapeutics, maker of a sickle-cell disease drug, for about $5 billion, people familiar with the matter said on.wsj.com/3P2AR48



Mirae Kim reposted

Guidepoint Insights recently hosted a call with a former DoorDash senior director to explore consumer trends and the impact of inflation on #fooddelivery. Learn more about $DASH here. bit.ly/3bt5xOn

DoorDash reported revenue that beat analysts’ expectations, boosted by a record number of orders, showing customers’ appetite for takeout isn’t waning despite rising inflation trib.al/Gr1iNf3



Mirae Kim reposted

Can $CYH cost-cut its way to profitability? Why might this be difficult, how could it impact quality of care, and why might drivers such as volumes and pricing mix remain challenged? A 35-year hospital veteran offers his perspectives. #CreditResearch bit.ly/3BNG7pp


Mirae Kim reposted

Guidepoint Qsight has recently gathered insights from our proprietary panel of aesthetic healthcare providers on how the current & expected economic environment will impact the aesthetic industry. Learn more from Guidepoint Qsight’s latest TRACKER Alerts: bit.ly/3SqPbXf

Guidepoint's tweet image. Guidepoint Qsight has recently gathered insights from our proprietary panel of aesthetic healthcare providers on how the current & expected economic environment will impact the aesthetic industry. Learn more from Guidepoint Qsight’s latest TRACKER Alerts: bit.ly/3SqPbXf

Mirae Kim reposted

With #mortgagerates rates pulling back from recent highs, Guidepoint Insights spoke with the Chief Economist of the @NAR_Research who made the case for a soft landing with a modest trough in existing and new home sales. #UShousing bit.ly/3vFHCCi


Mirae Kim reposted

A former $PINS head of strategy and corp development shares insight on growth potential as activist investor Elliott emerges as Pinterest's largest holder. bit.ly/3bqixEv


Mirae Kim reposted

Over the past month, we have gathered insights from our panel of Chimeric Antigen Receptor T-cell (CAR-T) healthcare facilities on the current and expected treatment landscape. Learn more from Guidepoint Qsight’s latest TRACKER Alerts here: qsight.guidepoint.com/tracker-alerts/

Guidepoint's tweet image. Over the past month, we have gathered insights from our panel of Chimeric Antigen Receptor T-cell (CAR-T) healthcare facilities on the current and expected treatment landscape. Learn more from Guidepoint Qsight’s latest TRACKER Alerts here: qsight.guidepoint.com/tracker-alerts/

Mirae Kim reposted

How can $DASH grow against a backdrop of price inflation, rising service rates, and increased competition? Join a Guidepoint Insights moderated expert call to explore these questions and more. $UBER $GRUB bit.ly/3bt5xOn


United States Trends

Loading...

Something went wrong.


Something went wrong.